Patents by Inventor Avedis Karadeolian

Avedis Karadeolian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180258057
    Abstract: The present invention provides processes for the preparation of Lesinurad (1), as well as intermediates useful in the preparation thereof. In particular, the processes of the invention utilize novel intermediate compounds of Formulas (3) and (11), which provide improvements over the known processes for the preparation of Lesinurad (1).
    Type: Application
    Filed: March 7, 2018
    Publication date: September 13, 2018
    Inventors: Prabhudas Bodhuri, Melanie R. A. Green, Avedis Karadeolian, Gamini Weeratunga, Boris Gorin
  • Publication number: 20180179226
    Abstract: The present invention provides processes for the preparation of Edoxaban (1) and salts thereof, as well as intermediates thereof. In particular, intermediate compounds and/or salts of the Formulae (3), (4), (6-A), (7-A), (8-A), (9-A) and (10-AS) are provided.
    Type: Application
    Filed: December 21, 2017
    Publication date: June 28, 2018
    Inventors: Prabhudas Bodhuri, Avedis Karadeolian, Eduardo Gustavo Cammisa, Stuart P. Green, Melanie R. A. Green, Alfredo Paul Ceccarelli
  • Patent number: 9260438
    Abstract: Solid and crystalline forms of tofacitinib hydrochloride and tofacitinib hydrobromide, processes for the preparation thereof and processes for the use thereof in preparing tofacitinib citrate are provided.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: February 16, 2016
    Assignee: Apotex Inc.
    Inventors: Prabhudas Bodhuri, Stuart P. Green, Fan Wang, Cameron L. McPhail, Eduardo Gustavo Cammisa, Avedis Karadeolian
  • Publication number: 20150225406
    Abstract: Solid and crystalline forms of tofacitinib hydrochloride and tofacitinib hydrobromide, processes for the preparation thereof and processes for the use thereof in preparing tofacitinib citrate are provided.
    Type: Application
    Filed: February 6, 2015
    Publication date: August 13, 2015
    Inventors: Prabhudas Bodhuri, Stuart P. Green, Fan Wang, Cameron L. McPhail, Eduardo Gustavo Cammisa, Avedis Karadeolian